SITAGLIPTIN HYDROCHLORIDE ORAL

1 reported adverse events

Drug classes: Dipeptidyl Peptidase 4 Inhibitor [EPC]

These side effects are most commonly reported by patients taking SITAGLIPTIN HYDROCHLORIDE ORAL:

# Side effect Count
0 ADVERSE EVENT 1
See all common reactions for SITAGLIPTIN HYDROCHLORIDE ORAL

SITAGLIPTIN HYDROCHLORIDE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADVERSE EVENT 1 0.0000
See all enriched reactions for SITAGLIPTIN HYDROCHLORIDE ORAL